Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 264
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03532204 | Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer | ||
| NCT04595565 | Sacituzumab Govitecan in Primary HER2-negative Breast Cancer | ||
| NCT03333356 | Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) | ||
| NCT05297617 | Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk | ||
| NCT01780220 | Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery | ||
| NCT05639413 | A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer | ||
| NCT03672331 | My Personalized Breast Screening | ||
| NCT03697850 | Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy | ||
| NCT03012620 | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types | ||
| NCT00003683 | Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer | ||
| NCT01993498 | Chronic Toxicities Related to Treatment in Patients With Localized Cancer | ||
| NCT04747054 | Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers | ||
| NCT07237256 | Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib | ||
| NCT01745757 | Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer | ||
| NCT03726775 | Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN | ||
| NCT00212121 | Radiation Dose Intensity Study in Breast Cancer in Young Women | ||
| NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | ||
| NCT02444390 | Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor | ||
| NCT04960735 | Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer | ||
| NCT05041842 | Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer | ||
| NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | ||
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | ||
| NCT07340567 | Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test | ||
| NCT01957436 | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | ||
| NCT02339532 | Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status | ||
| NCT04450836 | Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer | ||
| NCT04246606 | Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer | ||
| NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | ||
| NCT00104715 | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | ||
| NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT02393820 | Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma | ||
| NCT05443087 | TARGETed Therapy Drug MONITOring in DIGestive Oncology | ||
| NCT00005584 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | ||
| NCT00227747 | Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer | ||
| NCT01357486 | Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis | ||
| NCT04367870 | COVID-19 Detection Test in Oncology | ||
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III | ||
| NCT01143285 | Impact of Early and Active Nutritional and Dietary Management grade3 or More Toxicities Induced by Chemotherapy and Targeted Therapies Administered to Patients as First Intention for Non Surgical Metastatic Colorectal Cancer | ||
| NCT00005944 | Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer | ||
| NCT00003852 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | ||
| NCT03164655 | Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network | ||
| NCT03006432 | PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA | ||
| NCT02867033 | National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) | ||
| NCT04158362 | Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer | ||
| NCT07241273 | SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer | ||
| NCT00003654 | Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer | ||
| NCT02773004 | Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer | ||
| NCT00006119 | Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma | ||
| NCT02215265 | Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS) | ||
| NCT06333314 | Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI |
